Positive Momentum and Strong Growth Projections Reinforce Buy Rating for On Holding AG
Analyst Tom Nikic from Needham reiterated a Buy rating on On Holding AG (ONON – Research Report) and keeping the price target at $64.00.Stay ...
Buy Rating for Crispr Therapeutics AG: Strong Pipeline, Strategic Partnerships, and Financial Stability Drive Confidence
Analyst Gil Blum from Needham maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) and keeping the price target at ...